Elite Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-43,578
| Closed | -$1.21M | – | 43 |
|
|
2023
Q3 | $1.21M | Buy |
43,578
+15,640
| +56% | +$436K | 0.09% | 29 |
|
|
2023
Q2 | $952K | Buy |
27,938
+12,757
| +84% | +$435K | 0.07% | 31 |
|
|
2023
Q1 | $456K | Sell |
15,181
-259
| -2% | -$7.79K | 0.03% | 38 |
|
|
2022
Q4 | $436K | Sell |
15,440
-53
| -0.3% | -$1.5K | 0.04% | 39 |
|
|
2022
Q3 | $509K | Sell |
15,493
-581
| -4% | -$19.1K | 0.04% | 35 |
|
|
2022
Q2 | $506K | Buy |
16,074
+345
| +2% | +$10.9K | 0.08% | 34 |
|
|
2022
Q1 | $722K | Sell |
15,729
-724
| -4% | -$33.2K | 0.12% | 31 |
|
|
2021
Q4 | $1.01M | Sell |
16,453
-701
| -4% | -$42.9K | 0.14% | 29 |
|
|
2021
Q3 | $1.28M | Buy |
17,154
+685
| +4% | +$51.2K | 0.24% | 30 |
|
|
2021
Q2 | $1.52K | Buy |
16,469
+118
| +0.7% | +$11 | 0.14% | 26 |
|
|
2021
Q1 | $1.45K | Buy |
16,351
+253
| +2% | +$22 | 0.19% | 26 |
|
|
2020
Q4 | $1.5M | Buy |
+16,098
| New | +$1.5M | 0.19% | 23 |
|